resident & alumni news

$75 million deal: Invisible Sentinel sold to French biotech company

February 7, 2019  |  Philadelphia Business Journal

A Philadelphia life sciences company that developed DNA-based technology to quickly detect pathogens in food and beverages including wine and beer was acquired by French biotechnology company bioMérieux for $75 million.


Founded in 2006, Invisible Sentinel has grown to 40 employees and generated sales of about $9 million in 2018. Its Veriflow technology has generated more than 1 million tests sold since introduced in 2014.


Click here to read more.